Ethos Financial Group’s DexCom DXCM Stock Holding History

Ethos Financial Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,925	Closed	-$539K	–	489
2025 Q1	$539K	Hold	6,925	–	–	0.05%	221
2024 Q4	$539K	Buy	+6,925	New	+$513K	0.07%	151

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Ethos Financial Group's DXCM Position: Q2 2025 in Review

Ethos Financial Group sold out of DexCom (DXCM) in Q2 2025, closing a stake of 6,925 shares — an estimated $539K sold.

Ethos Financial Group first reported a position in DXCM in Q4 2024 and held it in 2 quarters. The position peaked at $539K in Q1 2025. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

Ethos Financial Group reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
Ethos Financial Group sold 6,925 DexCom shares in Q2 2025, an estimated $539K.
Ethos Financial Group first reported a position in DexCom in Q4 2024 and held it in 2 quarters.
Ethos Financial Group's DexCom position peaked at $539K in Q1 2025.
939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on Ethos Financial Group's 13F filing for Q2 2025, filed 6 Aug 2025.